Multiscale Analysis of Trauma
创伤的多尺度分析
基本信息
- 批准号:9264028
- 负责人:
- 金额:$ 75.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2021-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAcute Lung InjuryAgonistAlgorithmsAnimal ModelAntigensBehaviorBiochemicalBiochemistryBiologicalBiological AssayBiological MarkersBiological Neural NetworksBiologyBiomedical EngineeringBloodBlood CirculationBlood Coagulation DisordersBlood PlateletsBlood VesselsBlood VolumeBlood coagulationBlood specimenCardiacCase StudyCell DeathCell modelCellsCerealsClinicalClinical DataCoagulation ProcessComplementComplexComputer SimulationControlled StudyDNADataDatabasesDeep Vein ThrombosisDetectionDevelopmentDiagnosticDiffusionDoseElementsEndothelial CellsEndotheliumEventExposure toExtravasationFibrinolysisFunctional disorderGoalsHematologistHemorrhageHemostatic functionHistonesHormonalHumanIn VitroIndividualInjuryKineticsLifeLinkLiquid substanceMapsMeasurementMeasuresMediatingMedicalMethodsMicrofluidic MicrochipsMicrofluidicsModelingMusMuscleMutationOperative Surgical ProceduresOutputPathologicPathway interactionsPatient SimulationPatient-Focused OutcomesPatientsPennsylvaniaPeptide HydrolasesPerformancePharmacologyPlasmaPopulationProcessProductionReactionRecordsResearchRiskRuptureSafetyScanningScientistSepsisSeveritiesSideSignal PathwaySignal TransductionStimulusSurgeonTechniquesTestingThrombinThrombosisTimeTissue ModelTissuesTracerTrainingTransfusionTraumaTrauma patientUnited States National Institutes of HealthUniversitiesValidationVascular PermeabilitiesWhole BloodWhole OrganismWorkbasebiochemical modelclinical decision-makingcombinatorialcostcytokinedatabase designdesignendothelial dysfunctionexperimental studyhemodynamicshigh dimensionalityimprovedin vivoin vivo Modelinnovationintercellular cell adhesion moleculelaboratory experimentloss of functionmetermolecular scalemouse modelmulti-scale modelingneutrophilnovelpatient stratificationpressurepublic health relevancereceptorresponsesensorsimulationsyndecan
项目摘要
DESCRIPTION (provided by applicant): In response to PAR-15-085, the University of Pennsylvania and Princeton University have assembled an interdisciplinary team of bioengineers, computational scientists, trauma surgeons, and hematologists to develop a multiscale model of trauma. Better elucidation and quantitative measurement of blood reactions, platelet signaling, neutrophil signaling, and endothelial signaling pathways under hemodynamic conditions are directed at clinical needs in: (i) stratifying trauma induced coagulopathy (TIC) risks, (ii) improving the safety and efficacy of transfusion therapy, and (iii) identifying moleculr mechanisms that can be targeted pharmacologically or serve as improved biomarkers. Six specific aims are proposed: Aims 1 and 2 focus on the development of mechanistic and data-driven computer models of biochemical and cellular function relating to: protease cascades of coagulation, fibrinolysis, and complement assembly, as well as platelet, neutrophil and endothelial function. Aim 3 then develops a multiscale model of blood clotting and hemostatic function in a damaged blood vessel. The individual sub-models at the single cell level are combined into the unit vessel bleeding model which is related closely to laboratory experiments that test the functional performance of mouse and human patient blood under the extreme conditions of trauma. Aim 3 also involves microfluidic bleeding assays of human blood under diverse pathological conditions that explore bleeding scenarios involving combinatorial alterations of biochemistry and biology relevant to trauma. Aim 4 will implement "coarse projective integration" (CPI) to make prediction of the evolving systemic circulation and its interaction with a traumatized tissue where bleeding is quantified at the single cell to single vessel to tissue scale. These simulations are designed to validate an in silico trauma patient in order to stratify the risk of TIC. In Aim 5, the intensive use of fresh blood samples from trauma patients and annotated records from trauma patients will be part of the validation of the multiscale CPI algorithm. Key preliminary data demonstrates detection and quantification of platelet hypofunction in trauma patients. Aim 6 will utilize a novel in vivo mouse injury model to study bleeding and hemostasis in a calibrated model of trauma severity. This in vivo data will also be used to enhance the predictive capability of the multiscale model and to potentially identify biomarkers for stratifying TIC risks in humans. Also the mouse work emphasizes the use of novel fluorescent sensors developed specifically for this research. Overall, these aims represent the full integration of platelet, neutrophil, and endothelial signaling models with realistic and hierarchical hemodynamic/mass transport simulations that regulate bleeding and blood function at the various scales relevant to trauma.
描述(由申请人提供):为了响应 PAR-15-085,宾夕法尼亚大学和普林斯顿大学组建了一个由生物工程师、计算科学家、创伤外科医生和血液学家组成的跨学科团队,以开发一个多尺度的创伤模型,以更好地阐明和解释创伤。血流动力学条件下血液反应、血小板信号传导、中性粒细胞信号传导和内皮信号传导通路的测量针对以下方面的定量临床需求:(i) 分层创伤诱发的凝血病(TIC) 风险,(ii) 提高输血治疗的安全性和有效性,以及 (iii) 确定可药理学靶向或作为改进的生物标志物的分子机制: 目标 1 和 2 侧重于开发生物化学和细胞功能的机械和数据驱动计算机模型涉及:凝血、纤维蛋白溶解和补体组装的蛋白酶级联,以及血小板、中性粒细胞和内皮功能。然后,目标 3 开发了受损血管中血液凝固和止血功能的多尺度模型,将单细胞水平的各个子模型组合成单位血管出血模型,该模型与测试血管功能性能的实验室实验密切相关。目标 3 还涉及在不同病理条件下对人类血液进行微流体分析,以探索与创伤场景相关的生物化学和生物学的出血组合变化。实施“粗投影积分”(CPI)来预测不断变化的体循环及其与受伤组织的相互作用,其中出血在单细胞、单血管和组织规模上进行量化。这些模拟旨在验证计算机模拟创伤患者。为了对 TIC 风险进行分层,在目标 5 中,大量使用创伤患者的新鲜血液样本和创伤患者的注释记录将成为多尺度 CPI 算法验证的一部分,以证明检测和诊断的有效性。目标 6 将利用新型体内小鼠损伤模型来研究创伤严重程度校准模型中的出血和止血情况,该体内数据也将用于增强多尺度模型的预测能力。潜在地识别用于对人类 TIC 风险进行分层的生物标志物。此外,小鼠工作还强调使用专门为本研究开发的新型荧光传感器。总体而言,这些目标代表了血小板、中性粒细胞和内皮信号传导的完全整合。具有真实且分层的血流动力学/质量传输模拟的模型,可在与创伤相关的各种尺度上调节出血和血液功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT L DIAMOND其他文献
SCOTT L DIAMOND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT L DIAMOND', 18)}}的其他基金
Neonatal and Pediatric Platelet Function and Pharmacology
新生儿和儿童血小板功能和药理学
- 批准号:
9759659 - 财政年份:2018
- 资助金额:
$ 75.71万 - 项目类别:
Neonatal and Pediatric Platelet Function and Pharmacology
新生儿和儿童血小板功能和药理学
- 批准号:
9292339 - 财政年份:2015
- 资助金额:
$ 75.71万 - 项目类别:
Neonatal and Pediatric Platelet Function and Pharmacology
新生儿和儿童血小板功能和药理学
- 批准号:
9103240 - 财政年份:2015
- 资助金额:
$ 75.71万 - 项目类别:
Neonatal and Pediatric Platelet Function and Pharmacology
新生儿和儿童血小板功能和药理学
- 批准号:
8908392 - 财政年份:2015
- 资助金额:
$ 75.71万 - 项目类别:
Core C: Genomics and High Throughput Screening Core
核心 C:基因组学和高通量筛选核心
- 批准号:
8066104 - 财政年份:2010
- 资助金额:
$ 75.71万 - 项目类别:
相似国自然基金
免疫反应基因1(IRG1)在急性肺损伤中的作用及其转录调控机制研究
- 批准号:82300103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TRPV2-AMPK-PKM2信号轴介导的巨噬细胞能量代谢重编程在衰老后肠缺血再灌注所致急性肺损伤中的作用及机制
- 批准号:82372201
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Galectin-1抑制肺泡巨噬细胞线粒体损伤介导的NLRP3活化减轻流感致急性肺损伤的机制研究
- 批准号:82300005
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ANXA3调控肺微血管内皮细胞通透性在脓毒症急性肺损伤中的作用及机制研究
- 批准号:82372180
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PDHA1介导中性粒细胞NETosis在急性肺损伤中的作用及机制研究
- 批准号:82370086
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
- 批准号:
10751760 - 财政年份:2024
- 资助金额:
$ 75.71万 - 项目类别:
Development of a Neutrophil Degranulation Inhibitor to Treat ARDS
开发治疗 ARDS 的中性粒细胞脱颗粒抑制剂
- 批准号:
10697442 - 财政年份:2023
- 资助金额:
$ 75.71万 - 项目类别:
Predicting ECMO NeuroLogICal Injuries using mAchiNe Learning (PELICAN)
使用机器学习预测 ECMO 神经损伤 (PELICAN)
- 批准号:
10719312 - 财政年份:2023
- 资助金额:
$ 75.71万 - 项目类别:
Immune-epithelial progenitor interactions drive age-associated dysplastic lung repair post viral pneumonia
免疫上皮祖细胞相互作用驱动病毒性肺炎后与年龄相关的发育不良肺修复
- 批准号:
10751699 - 财政年份:2023
- 资助金额:
$ 75.71万 - 项目类别:
Development of a Neutrophil Degranulation Inhibitor to Treat ARDS
开发治疗 ARDS 的中性粒细胞脱颗粒抑制剂
- 批准号:
10697442 - 财政年份:2023
- 资助金额:
$ 75.71万 - 项目类别: